RxDoctor Payments Data

Malcolm Floyd, MD

Family Medicine · Americus, GANPI 1023323516

Payments from drug & device makers

$1,997in general payments, 2019–2025

Across 107 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$331
  • Lilly USA, LLC$265
  • GSK$199
  • AstraZeneca$151
  • Novartis$142
  • Sumitomo Pharma America, Inc.$115
  • plus $795 from 16 others

What the payments were for

  • Food & beverage$1,997100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,997 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$50,538
Medicare patients
139
Services billed
4,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide167$168,077
JardianceEmpagliflozin121$106,025
LinzessLinaclotide123$104,672
EliquisApixaban77$85,959
TradjentaLinagliptin74$62,672
OzempicSemaglutide59$62,268
FarxigaDapagliflozin Propanediol82$60,128
JanuviaSitagliptin Phosphate61$53,791
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$45,991
MyrbetriqMirabegron79$44,896
MounjaroTirzepatide33$41,487
XareltoRivaroxaban57$40,662
Xultophy 100-3.6Insulin Degludec/Liraglutide19$33,114
RybelsusSemaglutide21$32,923
GlyxambiEmpagliflozin/Linagliptin28$26,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Synjardy Xr$115$211,742249 claims
Lilly USA, LLCTrulicity, Mounjaro$265$209,563200 claims
Novo NordiskOzempic, Xultophy 100-3.6, Rybelsus, Tresiba$331$132,986115 claims
AbbVieLinzess$75$104,672123 claims
PfizerEliquis$15$85,95977 claims
MerckJanuvia, Lagevrio (Eua), Janumet$68$84,399101 claims
AstraZenecaFarxiga, Breztri Aerosphere$151$67,24793 claims
GSKTrelegy Ellipta$199$45,99158 claims
NovartisEntresto$142$23,02020 claims
Sumitomo Pharma America, Inc.Gemtesa$115$19,94229 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$26$12,05124 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$48$10,95413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Americus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →